What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Reckitt Benckiser's CEO, Kris Licht, highlighted India as a key growth driver, anticipating sustained strong volume growth ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

"Kyle's decades of financial, transactional and operational experience in our industry will make an immediate and positive ...

Stocks are swinging wildly this month, as President Trump’s latest tariff moves continue to send shockwaves through the markets. His ...

With its potential to become a regional genomics hub, Vietnam has been urged to prepare infrastructure and policies to ...

“While macro headlines/tweets continue to dictate stock performance, and we expect volatility to continue, we see biotech ...

helping you make more informed investment decisions in the biotech sector. TD (TSX:TD) Cowen maintained a Buy rating with a $62 target, anticipating strong first-quarter performance for Carvykti, with ...

Omnivore, one of India’s leading sustainability-focused venture capital firms, has released a report titled "India Life Sciences Startup Investing Report – A Five-Year Review" in partnership ...

Dr. David Meeker, CEO of Rhythm Pharma, says tariffs won't directly impact them but could stress the biotech sector. He warns FDA layoffs may slow drug approvals for rare diseases. Planes clip ...